Filter Options
Required*
Filter
Bloomington / Indiana / United States
0.0
Biolife plasma services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies. Our state of the are plasma donation facilities operate throughout the United States and Austria. Biolife is committed to safety: through superior service we strive to ensure the safety of our donors and the patients who receive life-saving plasma-based therapeutics.
Gainesville / Florida / United States
0.0
Located in Gainesville, Fla., Nabi Biopharmaceuticals is a global health care provider that offers preventive solutions to illness and premature death. The company leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the area of nicotine addiction. Nabi Biopharmaceuticals is currently developing NicVAX (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse. The company provides clinical outcomes for patients, saving lives and reducing the financial burden on the health care system.
Bolingbrook / Illinois / United States
0.0
Biolife plasma services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies. Our state of the are plasma donation facilities operate throughout the United States and Austria. Biolife is committed to safety: through superior service we strive to ensure the safety of our donors and the patients who receive life-saving plasma-based therapeutics.
Terre Haute / Indiana / United States
0.0
Kyle / Texas / United States
0.0
Biolife plasma services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies. Our state of the are plasma donation facilities operate throughout the United States and Austria. Biolife is committed to safety: through superior service we strive to ensure the safety of our donors and the patients who receive life-saving plasma-based therapeutics.